Dr. Shineman will oversee all programs, activities and staff within the Research and Medical Programs Department, which endeavors to advance the understanding of Tourette & Tic Disorders and facilitate the development of effective therapies for these disorders. Prior to joining TAA, Dr. Shineman spent nine years at the Alzheimer’s Drug Discovery Foundation directing the Foundation’s drug discovery and development grant programs and strategic initiatives with foundations, government and industry partners.
Dr. Shineman earned a Ph.D. in Cell and Molecular Biology from the University of Pennsylvania working in the Center for Neurodegenerative Disease Research. She received a B.A. in Biology with a Nutrition concentration from Cornell University and was named a Howard Hughes Research Scholar. In addition to maintaining various professional memberships, Dr. Shineman has also authored numerous articles and peer-reviewed publications.